Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

PAVmed Inc (PAVMZ)

  • Business News
  • Nov. 13, 2025, 13:17 UTC
  • 8
  • 0 comments

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Market reaction Comment Full text

Biofrontera Inc. (BFRI)

  • Business News
  • Nov. 13, 2025, 13:15 UTC
  • 10
  • 0 comments

Biofrontera Notification (BFRI)

Market reaction Comment Full text

Lucid Diagnostics Inc. (LUCD)

  • Business News
  • Nov. 13, 2025, 13:15 UTC
  • 17
  • 1 comments

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Market reaction Comment Full text

Nano X Imaging Ltd (NNOX)

  • Business News
  • Nov. 13, 2025, 13:15 UTC
  • 20
  • 1 comments

Nanox to Launch FDA-Cleared Nanox.ARC X and Present development of new AI innovations at RSNA 2025 Annual Meeting

Market reaction Comment Full text

Biofrontera Inc. (BFRI)

  • Business News
  • Nov. 13, 2025, 13:15 UTC
  • 18
  • 1 comments

Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update

Market reaction Comment Full text

PAVmed Inc (PAVM)

  • Business News
  • Nov. 13, 2025, 13:15 UTC
  • 20
  • 1 comments

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Market reaction Comment Full text

EPAM Systems Inc. (EPAM)

  • Business News
  • Nov. 13, 2025, 13:05 UTC
  • 10
  • 0 comments

EPAM Systems, Inc. - EPAM Wins the 2025 Microsoft Innovate with Azure AI Platform Partner of the Year Award

Market reaction Comment Full text

Nortech Systems Incorporated (NSYS)

  • Business News
  • Nov. 13, 2025, 13:05 UTC
  • 19
  • 1 comments

Nortech Systems Reports Third Quarter Results

Market reaction Comment Full text

Tharimmune Inc (THAR)

  • Business News
  • Nov. 13, 2025, 13:05 UTC
  • 19
  • 1 comments

Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids

Market reaction Comment Full text

PAVmed Inc (PAVMZ)

  • Business News
  • Nov. 13, 2025, 13:02 UTC
  • 9
  • 0 comments

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

Market reaction Comment Full text
  • Previous
  • 658
  • 659
  • 660
  • 661
  • 662
  • Next

Search

News categories

  • Technical Exchange News(10960)
  • Event(2424)
  • SEC News(192986)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125661)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin